FDA Inspection
Anish Shah, M.D.Anish Shah, M.D. – FDA Inspection, Dec 16, 2022
Record Details
This FDA Inspection record concerns Anish Shah, M.D., with an inspection on December 16, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Anish Shah, M.D.
- Inspection Date
- December 16, 2022
- Product Type
- Drugs
View Company Profile
ID · 3ad2cb93-9775-4487-9e64-0287e50232ab
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1193537
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.50Ensuring compliance with plan and protocol
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Anish Shah, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 15, 2025 | Not classified | San Francisco District Office | Bioresearch Monitoring: Human Drugs |
Other documents for Anish Shah, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.